CELL THERAPEUTICS

Codice
CTIC.MI
Risorse esterne
Opinione della community
Prezzo Variazione Volume
3.75 0 €
(0.00%)
35536
P/E Obiettivo ad 1anno
0 0 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 50
Sell : 19

Aasi Luca lolibe pierino sony249 Fabrizio Furio Marco marco zorz renato

Commenti


Notizie

Trading Summary: Watching Shares of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - Searcy News

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) has a current Piotroski F-Score of 2. The mission of the F-Score is to help spot companies with strengthening balance sheets, and to weed out poor performers. The Piotroski F-Score is named after its ...altro » Leggi

Brainstorm Cell Therapeutics (BCLI) Receiving Very Favorable News Coverage, Study Finds - Sports Perspectives

AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Brainstorm Cell Therapeutics earned a news sentiment score of 0.56 on AlphaOne's scale. AlphaOne also gave ... Leggi

Brainstorm Cell Therapeutics Inc (BCLI) PT Set at $8.00 by Maxim Group - Markets Daily

Brainstorm Cell Therapeutics (NASDAQ:BCLI) traded down 0.74% during mid-day trading on Monday, reaching $4.04. 29,784 shares of the company's stock traded hands. The stock's market capitalization is $75.50 million. Brainstorm Cell Therapeutics has a ... Leggi

Traders Take Note: Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Stock Drops, Weakness in Technical Momentum - CML News

Take Note: Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and ...altro » Leggi

Equity in Focus: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - Business Daily

We can now shift our focus to some alternate company data on shares of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI). The stock has a current ATR of 0.18. When applying indicators for technical analysis, traders and investors may choose to examine ...altro » Leggi

Price Alert: Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Stock Nears Resistance -- Technicals Hit Strength - CML News

Price Alert: Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) has now crossed into technical strength -- watch the technical oscillators for momentum gaps. The company has not quite broken out to extreme strength, but rather sits at a four bull momentum ... Leggi

Maxim Group Analysts Give Brainstorm Cell Therapeutics Inc (BCLI) a $8.00 Price Target - Sports Perspectives

Shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI) traded down 0.24% during trading on Wednesday, reaching $4.11. The company's stock had a trading volume of 23,621 shares. The stock has a 50-day moving average of $4.07 and a 200-day moving ... Leggi

Biotech Stocks Under Scanner -- Juno Therapeutics, Nektar ... - PR Newswire (press release)

The Biotech space consists of companies engaged in the research and development of new drugs, medical devices, and procedures. The industry includes the ...altro » Leggi

What the Charts are Saying About Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - Rives Journal

Traders and investors tracking shares of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) may be examining the company's FCF or Free Cash Flow. FCF is a measure of a company's financial health. FCF is calculated by subtracting capital expenditures from ...altro » Leggi

Brainstorm Cell Therapeutics (BCLI) Getting Positive Press Coverage, Analysis Shows - Sports Perspectives

AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Brainstorm Cell Therapeutics earned a media sentiment score of 0.35 on AlphaOne's scale. AlphaOne also ... Leggi